Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/18/2026

1. NFLX
2. ISRG
3. SPY
4. AAPL
5. USB
6. NVDA
7. STT
8. SPCX
9. BA
10. GCTK

Go back to Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
(NASDAQ: SLGL) Delayed: 83.20 +5.12 (6.56%)
Previous Close $78.08    52 Week High $ 
Open $77.68    52 Week Low $ 
Day High $86.90    P/E N/A 
Day Low $77.68    EPS $ 
Volume 40,556